Rehmannioside A Inhibits TRAF6/MAPK Pathway and Improves Psoriasis by Interfering with the Interaction of HaCaT Cells with IL-17ALili Yuan, Chunyu Cao|Clinical Cosmetic and Investigational Dermatology|2023Cited by 18